期刊文献+

大肠癌组织p16蛋白表达与临床病理关系的探讨 被引量:2

Expression of P16 protein in colorectal carcinoma tissue and its correlation with clinical pathology
下载PDF
导出
摘要 目的 研究大肠癌组织P 16蛋白表达及其与临床病理学特征的关系?方法 采用免疫组织化学ABC法检测53例大肠癌组织中P 16蛋白的表达?结果 大肠癌组织中P 16蛋白表达率为35.8%,P 16表达随肿瘤分化程度的降低而减弱(P<0.05) ?Dukes分期,AB期P 16表达率高于CD期,分别为51.5%和10.0%,有显著性差异(P<0.05)?结论 P 16蛋白表达缺失与大肠癌发生有关,并可作为临床判断肿瘤分化程度及Dukes分期的重要参考指标? Objective To investigate the expression of p16 protein in colorectal carcimoma tissue and its correlation with clinicopathological featares. Methods The expression of p16 protein was detected by ABC immunohistohistochemical method in 53 cases of colorectal carcinoma.Res ults The detection rates of p16 protein was 35.8% in colon cancer.according to Dukes staging,the positive rate in A,B grades (51.5%) was higer than the rate in C,D grades (10.0%).The expression of p16 protein was reduced with the malignancy of cancerous tissues (P<0.05) .Conclusion The mutation and loss of p16 gene was closely related to the occurrence and development of colorect cancer.p16 gene assay plays an important role in the estimation of differentiation degree of cancerous tissues and Dukes stages.
出处 《武警医学》 CAS 2001年第11期656-658,共3页 Medical Journal of the Chinese People's Armed Police Force
关键词 大肠肿瘤 P16基因 病理学 Colorectal neoplasms p16 gene Pathology
  • 相关文献

参考文献2

共引文献20

同被引文献20

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 2吴晓华,张莘,周文阔,易喜贤,吴涛,徐惠绵.p16和PTEN抑癌基因蛋白在结直肠腺癌组织中的表达及临床意义[J].中国肿瘤临床与康复,2006,13(1):11-13. 被引量:2
  • 3Szynglarewicz B, Grzebieniak Z, Forgacz J, et al. Prognostic significance of clinical and pathomorphological factors in colorectal cancer: a uni - and multivariate analysis[ J]. Poi Merkuriusz Lek,2004,17(102) :586 - 589.
  • 4Kubota K, Akasu T, Fujita S, et al. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas [ J ]. Hepatogastroenter - ology,2004,51 (55) :142 - 146.
  • 5Stelzner S, Hellmich G, Koch R, et al. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis[ J ]. J Surg Oncol,2005 Mar 15,89 (4) :211 - 217.
  • 6Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell - cycle control causing specific inhibition of cyclin D/CDK4 [ J ]. Nature, 1993 Dec 16,366(6456) :704-707.
  • 7Masson - D, Denis - MG, Lustenberger - P. Limitations of CD44v6 amplifi - cation for the detection of tumour cells in the blood of colorectal cancer patients [ J ]. Br - J - Cancer, 2000,82 (7) : 1283 - 1289.
  • 8Imazeki F, Yokosuka O, Yarnaguehi T, et al. Expression of variant CD44 messenger RNA in colorectal adenocareinomas and adenomatous polys in humans[ J ]. Gastroenlerology, 1996,110:362 - 3688.
  • 9Endl E, Hollmann C, Gerdes J, et al. Antibodies against the Ki67 protein:assessment of the growth fraction and tools for cell cycle analysis [ J]. Methods Cell Biol,2001,63:399 -418.
  • 10Kamb A,Gruis NA,Weaver-Feldhaus J. A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,(5157):436-440.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部